Aemetis, Inc. (NASDAQ:AMTX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Aemetis, Inc. (NASDAQ:AMTX) has received a consensus recommendation of “Moderate Buy” from the five research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $12.95.

Several equities analysts have weighed in on AMTX shares. Ascendiant Capital Markets lowered their target price on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Friday, November 15th.

Institutional Investors Weigh In On Aemetis

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. FMR LLC increased its holdings in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA bought a new position in shares of Aemetis during the 2nd quarter valued at $70,000. Barclays PLC lifted its stake in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after purchasing an additional 34,816 shares during the last quarter. Rhumbline Advisers boosted its holdings in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP bought a new stake in Aemetis in the third quarter worth $177,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Price Performance

Aemetis stock opened at $2.70 on Thursday. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03. The firm’s 50 day simple moving average is $3.30 and its 200-day simple moving average is $3.01. The company has a market cap of $134.28 million, a P/E ratio of -1.19 and a beta of 1.35.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period last year, the firm earned ($0.59) earnings per share. On average, analysts expect that Aemetis will post -2.02 EPS for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.